Free Trial

3,805 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Acquired by RWA Wealth Partners LLC

Ryan Specialty logo with Finance background
Remove Ads

RWA Wealth Partners LLC bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,805 shares of the company's stock, valued at approximately $244,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in RYAN. JPMorgan Chase & Co. increased its stake in Ryan Specialty by 107.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock worth $30,504,000 after purchasing an additional 238,064 shares in the last quarter. Bar Harbor Wealth Management boosted its holdings in shares of Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock valued at $10,835,000 after buying an additional 9,482 shares during the period. Barclays PLC increased its position in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after acquiring an additional 17,267 shares in the last quarter. Teachers Retirement System of The State of Kentucky raised its holdings in shares of Ryan Specialty by 51.5% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company's stock worth $2,042,000 after acquiring an additional 10,460 shares during the period. Finally, HighTower Advisors LLC lifted its position in Ryan Specialty by 101.6% in the 3rd quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock valued at $2,661,000 after acquiring an additional 20,139 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the transaction, the director now owns 45,409 shares in the company, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 241,360 shares of company stock worth $16,006,428 over the last ninety days. Insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. UBS Group lifted their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research note on Friday, February 21st. Royal Bank of Canada decreased their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. Finally, Wells Fargo & Company boosted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $75.27.

Check Out Our Latest Research Report on Ryan Specialty

Ryan Specialty Stock Performance

Ryan Specialty stock traded down $5.38 during midday trading on Friday, reaching $70.55. 1,434,020 shares of the company's stock were exchanged, compared to its average volume of 932,127. The stock's 50-day simple moving average is $69.60 and its 200 day simple moving average is $68.68. The firm has a market cap of $18.48 billion, a price-to-earnings ratio of 102.25, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's payout ratio is 69.57%.

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads